ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
AEG
|
AEGON N.V.
|
US
|
NYSE
|
ANIX
|
Anixa Biosciences, Inc.
|
US
|
NASDAQ
|
ATOS
|
Atossa Genetics Inc.
|
US
|
NASDAQ
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
BDTX
|
Black Diamond Therapeutics, Inc.
|
US
|
NASDAQ
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
BNOX
|
Bionomics Limited
|
US
|
NASDAQ
|
BYSI
|
BeyondSpring, Inc.
|
US
|
NASDAQ
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
CDMO
|
Avid Bioservices, Inc.
|
US
|
NASDAQ
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
DTIL
|
Precision BioSciences, Inc.
|
US
|
NASDAQ
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|